SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-18-003715
Filing Date
2018-12-14
Accepted
2018-12-14 16:47:59
Documents
6
Period of Report
2018-12-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K sonoma_8k.htm 8-K 25713
2 SEPARATION AND MUTUAL RELEASE - JIM SCHUTZ sonoma_8k-ex1001.htm EX-10.1 58899
3 SEPARATION AND MUTUAL RELEASE - ROBERT E. MILLER sonoma_8k-ex1002.htm EX-10.2 57801
4 EMPLOYMENT AGREEMENT - FREDERICK SANDFORD sonoma_8k-ex1003.htm EX-10.3 107411
5 RESIGNATION LETTER sonoma_8k-ex1701.htm EX-17.1 3610
6 GRAPHIC image_001.jpg GRAPHIC 3227
  Complete submission text file 0001683168-18-003715.txt   259327
Mailing Address 1129 N. MCDOWELL BLVD. PETALUMA CA 94954
Business Address 1129 N. MCDOWELL BLVD. PETALUMA CA 94954 707-283-0550
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

IRS No.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-33216 | Film No.: 181236105
SIC: 2834 Pharmaceutical Preparations